Neonatal jaundice: physiologic variation or pathologic process.
Neonatal hyperbilirubinemia and jaundice affect approximately 60% of the 4 million newborns in the United States each year. Jaundice results from bilirubin deposition in the skin and mucous membranes, becoming clinically visible at a serum bilirubin level of 5 to 7 mg/dL. At a higher but undefined level, bilirubin may deposit in the brain where it can cause transient dysfunction or permanent neurologic impairment.
Reiser
Diana J
DJ
Inpatient Perinatal Services, Saint Luke's Hospital of Kansas City, 4401 Wornall Road, Kansas City, MO 64111, USA. dreiser@saint-lukes.org
D000745:Anemia, Hemolytic, Congenital / Q000150:complications; D001663:Bilirubin / Q000097:blood / Q000502:physiology; D001942:Breast Feeding; D004899:Erythroblastosis, Fetal / Q000150:complications; D006801:Humans; D006932:Hyperbilirubinemia / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology* / Q000628:therapy; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology* / Q000628:therapy; D010351:Patient Discharge; D010789:Phototherapy
D001663:Bilirubin